Research and innovation areas
Highlights
-
Commission steps up research funding with €120 million for 11 new projects to tackle the virus and its variants
The Commission has short-listed 11 new projects worth €120 million from Horizon Europe, the biggest European research and innovation programme (2021-2027), for supporting and enabling urgent research into the coronavirus and its variants. This funding is part of a wide range of research and innovation actions taken to fight the coronavirus and contributes to the Commission's overall action to prevent, mitigate and respond to the impact of the virus and its variants, in line with the new European bio-defence preparedness plan HERA Incubator. The 11 short-listed projects involve 312 research teams from 40 countries, including 38 participants from 23 countries outside of the EU.
- 23 June 2021 - Commission launches the Coronavirus Global R&I Collaboration Portal
- 6 May 2021 - Commission proposes EU Strategy for the development and availability of therapeutics - Factsheet
- 7 April 2021 - Commission mobilises €123 million for research and innovation to combat the threat of coronavirus variants
- 17 February 2021 - EU to invest €150 million for research to counter coronavirus variants
- 25 March 2021 - EU-funded researchers develop potential new treatment against SARS-CoV-2
- 10 March 2021 - EU support to innovators yields promising results one year on - Factsheet
- 8 January 2021 - EU funded clinical trial finds new treatments to be effective
- 7 December 2020 - JRC releases new reference materials for quality control of antibody tests
- 11 November 2020 - EC invests in preparedness and response to infectious disease outbreaks
- 5 November - €128 million granted for research on socio-economic impact of pandemic
- 30 September 2020 - €459 million invested in coronavirus projects so far in 2020
- 28 July 2020 - Commission launches a Manifesto to maximise research results
- 6 July 2020 - Commission and EIB provide CureVac with a €75 million financing
- 17 June 2020 - Commission unveils EU vaccines strategy - R&I for vaccine development
- 11 June 2020 - EIB to provide BioNTech with up to €100 million in debt financing for vaccine development and manufacturing
- 10 June 2020 - EU strengthens action to tackle coronavirus disinformation
- 8 June 2020 - EU grants €314 million to innovative companies to combat virus and support recovery
- 14 May 2020 - ERA corona platform offers one-stop shop for research and innovation funding
- 12 May 2020 - €117 million granted for treatments and diagnostics through the ΙΜΙ
- 4 May 2020 - Coronavirus Global Response, €1 billion will be mobilised to fight virus
- 6 March 2020 - 18 new research projects awarded €48.2 million - Factsheet
Latest
Documents
Departments